Meyka Pro banner
Privia Health Group, Inc.

Stay Updated with the Latest Privia Health Group, Inc. PRVA News in Real Time

Find PRVA news now at Meyka AI. Stay informed with the latest Privia Health Group, Inc. stocks updates, including price news, market analysis, and expert insights.

PRVANASDAQ
HealthcareMedical - Healthcare Information Services
$25.50
$0.53(2.12%)
U.S. Market opens in 63h 22m
1.6 Million Eggs Recalled Over Salmonella Risk Across Six States
📅 in about 2 hours

1.6 Million Eggs Recalled Over Salmonella Risk Across Six States

Midwest Poultry Services recalls 1.6 million dozen eggs over potential salmonella contamination. Affected eggs sold at Kroger and Brookshire stores across six states with best-by dates through August 17.

Read more 12
Midwest Poultry Recalls 1.6M Dozen Eggs Over Salmonella Risk, July 24
📅 in 14 minutes

Midwest Poultry Recalls 1.6M Dozen Eggs Over Salmonella Risk, July 24

Midwest Poultry Services recalls 1.6 million dozen eggs over potential salmonella contamination. Affected eggs sold at Kroger and Brookshire’s in six states. Check carton codes P-1950 or 0840962 for refunds.

Read more 12
discoverIE Group (LSE: DSCV) Shares Soar 12% as Strong Q1 Orders and Sales Beat Expectations
📅 5 hours ago

discoverIE Group (LSE: DSCV) Shares Soar 12% as Strong Q1 Orders and Sales Beat Expectations

discoverIE Group shares jumped 12% on Friday, July 24, 2026, after a strong Q1 trading update. Group orders rose 31% organically, while sales climbed 6% organically. The book-to-bill ratio stood at 1.15, signaling robust future demand. Shares moved from around 685p to near 767p following the announcement. Full-year adjusted earnings are now tracking ahead of…

Read more 12
GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24
📅 6 hours ago

GLP-1 Weight Loss Drugs Linked to Hair Loss Risk, BMJ Study Finds July 24

New BMJ study finds GLP-1 weight loss drugs like Ozempic and Mounjaro linked to 37-68% higher hair loss risk. Researchers say the absolute risk remains low and hair loss is typically reversible.

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24
📅 7 hours ago

Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Generic Zyrtec recalled nationwide due to contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Check your bottles.

Read more 12
HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership
📅 7 hours ago

HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership

HSBC agreed to sell its Singapore life and health insurance business to Allianz on July 24, 2026. The deal values HSBC Life Singapore at S$2.7 billion, or roughly £1.6 billion. It will also enter a 15-year exclusive bancassurance partnership with the German insurer. The transaction generates a pre-tax gain of $1.8 billion and lifts HSBC’s…

Read more 12
S&P/NZX 50 Index Little Changed as Oil Rally Weighs on Market Sentiment
📅 9 hours ago

S&P/NZX 50 Index Little Changed as Oil Rally Weighs on Market Sentiment

The S&P/NZX 50 Index traded down 0.4% on Friday, July 24, 2026, as surging oil prices pressured sentiment. Despite the pullback, the benchmark remains up 0.4% over the past five trading days. New Zealand’s index has gained 2.6% over the past month and 7.4% over the past year.  Brent crude traded near $100.40 a barrel…

Read more 12
Intel Stock Soars After Fastest Revenue Growth in Nearly 15 Years
📅 9 hours ago

Intel Stock Soars After Fastest Revenue Growth in Nearly 15 Years

Intel stock surged after the chipmaker posted its strongest quarterly revenue growth in more than 15 years. Second-quarter 2026 revenue reached $16.1 billion, up 25% year-over-year, crushing the $14.42 billion consensus estimate. Adjusted earnings per share came in at 42 cents, doubling Wall Street’s 21-cent forecast.  Intel stock initially jumped 13% in after-hours trading Thursday…

Read more 12
Intel Jumps 7% on Q2 Earnings Beat as AI Demand Surges
📅 10 hours ago

Intel Jumps 7% on Q2 Earnings Beat as AI Demand Surges

Intel stock surges after Q2 earnings beat $16.1B revenue, 25% growth. Data center revenue jumped 60% as AI demand outpaces supply. Meyka grades INTC a B-Hold.

Read more 12

PRVA News FAQ